Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: A prospective observational study in the Nordic countries

International Journal of COPD

Volumn 7, Issue , 2012, Pages 571-576

  Gudmundsson, Gunnar ^a,b   Ulrik, Charlotte Suppli ^c   Gislason, Thorarinn ^a,b   Lindberg, Eva ^d   Brøndum, Eva ^c   Bakke, Per ^e   Janson, Christer ^c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UPPSALA UNIVERSITY   (Sweden)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute exacerbation; Co morbidity; Diabetes; Long term mortality; Lung function

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; AGE; AGED; CHI SQUARE DISTRIBUTION; COMORBIDITY; EUROPE; HOSPITALIZATION; KAPLAN MEIER METHOD; LUNG; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; REGISTER; RISK; SPIROMETRY; STATISTICS; SURVIVOR; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DIABETES MELLITUS; EUROPE; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SPIROMETRY; SURVIVORS; TIME FACTORS;

EID: 84872259324     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S34466     Document Type: Article

References (34)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011. Available from: http://www.goldcopd.org/. Accessed March 17, 2012.
2. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441-1448.
3. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive disease. Am J Respir Crit Care Med. 1996;154:959-967.
4. Gudmundsson G, Gislason T, Janson C, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidities. Respir Res. 2006;7:109.
5. Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou AJ. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. Gen Intern Med. 2009;24:1043-1048.
6. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26:234-241.
7. Fruchter O, Yialga M. Cardiac-troponin-I predicts long-term mortality in chronic obstructive pulmonary disease. COPD. 2009;6:155-161.
8. Calverley PMA, Anderson JA, Celli B, for the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775-789.
9. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD. A retrospective study. Chest. 2005;128:518-524.
10. Steinmetz J, Rasmussen LS, Nielsen SL. Long-term prognosis for patients with COPD treated in the prehospital setting. Is it influenced by hospital admission? Chest. 2006;130:676-680.
11. Groenewegen KH, Schols AM, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459-467.
12. SolerCataluña JJ, MartínezGarcía MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60: 925-931.
13. Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: A multicentre study in the Nordic countries. Respir Med. 2006;100:87-93.
14. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalization in COPD: Health status, anxiety and depression. Eur Respir J. 2005;26:414-419.
15. European Community for Coal and Steel. Standardisation of lung function tests. Clin Respir Phys. 1983;19(Suppl 5):22-27.
16. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321-1327.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
18. Terzano C, Conti V, Di Stefano F, et al. Comorbidity, hospitalization and mortality in COPD: Result from a Longitudinal Study. Lung. 2010; 128:321-329.
19. Steinmetz J, Rasmussen LS, Nielsen SL. Long-term prognosis for patients with COPD treated in the prehospital setting. Is it influenced by hospital admission? Chest. 2006;130:676-680.
20. Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66:585-590.
21. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-1440.
22. Lundback B, Eriksson B, Lindberg A, et al. A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. COPD. 2009;6:263-271.
23. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58: 388-393.
24. Galizia G, Cacciatore F, Testa G, et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res. 2011;23:118-125.
25. Hurst JR, Vestbo J, Anzueto A, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-1138.
26. Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Resp Med. 2007;101:1954-1960.
27. Mannino DM, Doherty DE, Buist SA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Resp Med. 2006;100:115-122.
28. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur Respir J. 2008;32:962-969.
29. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791-1797.
30. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional depletion in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856-1861.
31. Zielinski J, McNee W, Wedzicha JA, et al. Causes of death in patients with COPD and chronic respiratory failure. Mon Arch Chest Dis. 1997; 52:43-47.
32. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing. 2002;31:137-140.
33. Turner MC, Chen Y, Krewaki D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176:285-290.
34. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respire J. 2003;22:809-814.